Russia's constant threats to grind everyone to radiation ash are forcing the domestic pharmaceutical industry to react.
The Ministry of Health of Ukraine received 5, 25 million doses of the domestic drug “Potassium Iodide-125-Darnitsa”, which was created by the pharmaceutical company “Darnitsa” , in particular, in preparation for the state's potential radiation threat. This was reported by the company's press service.
The drug was created in accordance with the regulations on iodine prophylaxis in the event of a radiation accident (Order of the Ministry of Health of Ukraine of March 9, 2021 № 408).
< p>In total, to protect Ukrainians, 6.71 million doses of the drug “Potassium Iodide-125-Darnitsa” were produced, which allows for iodine prophylaxis if necessary for more than 6 million people. From this batch, the manufacturer transferred 5.25 million doses worth UAH 69 million to the Public Health Center of the Ministry of Health of Ukraine. The company plans to release another 1.5 million doses in May.
Potassium iodide is used to protect the thyroid gland from the accumulation of radiation. The risk of radiation damage to the thyroid gland can be reduced or even prevented with the timely appointment of iodine prophylaxis. The optimal effect of iodine prophylaxis is achieved by preventive intake of potassium iodide for 6 hours or less or simultaneously with the entry of radioactive isotopes of iodine or entering the contaminated area. Intake of potassium iodide 6 hours after entering the contaminated area with radioactive isotopes of iodine leads to a 2-fold reduction in the radiation dose, and if taken after 24 hours – the protective effect is almost absent. A single dose of potassium iodide provides protection for about 24 hours. The prophylactic dose of potassium iodide should be taken only after the official notification of the threat of emissions from the state and the need for iodine prophylaxis.
Read also: Interaction with leaders in the pharmaceutical industry is the key to national security – Lyashko
It will be recalled that the World Health Organization (WHO) has officially identified the domestic pharmaceutical company Darnytsia as the only one in Ukraine that will receive mRNA-based vaccine technology .
